Follow the 엔바이오니아 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the authority of DART (FSS). Operating in the Industrials sector, 엔바이오니아 has recorded 53 public disclosures. Market capitalisation: €34.4bn. The latest transaction was filed on 7 May 2026 (Sale). Among the most active insiders: 한정철. All data is accessible without an account.
53
Insider Decl.
n/a
Thresholds
n/a
4 ops.
Buy Volume
n/a
33 ops.
Sell Volume
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 28,644 of 29,062 companies
8.4
score / 100
Value
7
Quality
9
FCF yld-47%
Earn yld-20%
EV/EBITDA·
ROE-25%
Gross mgn13%
Net mgn-65%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.